SBIR/STTR Research Award

Electrochemical Screening of Multiple Enzymes Relevant to Organophosphate Poisioning

Award identifier 0264b8964e00dc0f8da8c649f3b723fe9812d0b9e5bcf4755051ad9542e5c6d3Awarding agency Department of Defense · Office for Chemical and Biological Defense

Award amount

$70,000

Program and phase

SBIR · Phase I

Award year

2010

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Office for Chemical and Biological Defense
Recipient company
LYNNTECH INC.
Proposal award date
2010-06-15
Contract end date
2010-12-14
UEI
PMVAL8J63516
Solicitation number
2010.1
Topic code
CBD10-108

Research abstract

Organophosphorus (OP) compounds have been extensively used as pesticides and chemical warfare agents . Potential OPs exposure exists both on the battlefield and in the civilian sector. OPs exposure inhibits enzyme activity, allowing excess acetylcholine to accumulate. Screening of multiple enzymes is highly desirable because it may provide a comprehensive description of the warrior’s capacity for low level OP exposure. Current screening use the colorimetric Ellman assay based on the hydrolysis of acetylthiocholine. Some alternative approaches, such as radiometric assay, immunoassay, fluorescence, chemiluminescence, or mass spectroscopy, have been reported for sensitive detection of enzyme activities. However, these assays are tedious and/or time-consuming, require expensive and sophisticated instruments, or are limited to a single enzyme. Thus, development of high-throughput, minimally invasive blood protocol to measure the human profile of enzymes affected by organophosphate chemical warfare agents is needed. It will provide the army and general public health clinics the capability of screening and confirming exposure of soldiers/agricultural workers/first responders to chemical warfare agents/pesticides/or other such toxic chemicals. Lynntech proposes to develop a simple, rapid, sensitive, hand-held field deployable biomonitoring device based on electrochemical detection principles. During Phase I, the proof-of-concept will be demonstrated. During Phase II, prototype assays will be developed.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

1,079 SBIR/STTR records share this UEI (1988–2025). Reported award amounts total $327,411,388. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, Department of Health and Human Services, National Aeronautics and Space Administration, Department of Energy, National Science Foundation, Environmental Protection Agency

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.